1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow sarilumab: new trials by email Literature Review of sarilumab trials Research Report on sarilumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET) Sarilumab 200 MG/1.14 ML Subcutaneous Solution [KEVZARA] - Rheumatoid Arthritis, Atherosclerosis | Phase 4 | Unknown | Instituto de Investigación Marqués de Valdecilla | 20 | 2020-04-30 | 2020-04-27 |
| Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis SARILUMAB, Azathioprine, Chloroquine - Rheumatoid Arthritis | Phase 4 | Completed | Sanofi | 84 | 2018-03-05 | 2022-04-28 |
Arthritis, Rheumatoid (2) · Atherosclerosis (1)
Instituto de Investigación Marqués de Valdecilla (1) · Sanofi (1)
France (1)
2017 (1)